Dr. Jeffrey A. Wesson, MD

Dr. Wesson practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Wesson's NPI, 1326090879, was assigned on May 16, 2006. Dr. Wesson graduated from Medical College of Wisconsin in 1994. Dr. Wesson holds Wisconsin license 37081.

Dr. Wesson's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Wesson's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wesson practices. Vendor and product names are available with a free account.

Nephrology is Dr. Wesson's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Wesson is licensed in Wisconsin.

CMS data shows 16 Medicare services from Dr. Wesson across 1 procedure code in 2021, all of them office visits, for 38 Medicare patients. Medicare paid $675 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 38 Medicare patients who saw Dr. Wesson in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wesson's median patient age at 58, with 57% women.

In 2024, Dr. Wesson wrote 30 Medicare Part D claims. 93% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $183 in total drug cost. In 2023, CMS named 22 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Wesson for performance year 2024, reported as part of a group. Dr. Wesson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wesson as offering telehealth.

Dmand AI links 13 papers to Dr. Wesson, published from 2012 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Calcium Oxalate, Kidney Calculi and Crystallization. Dr. Wesson has published most often in Urolithiasis. Dr. Wesson's most frequent co-authors are Carley M. Davis, MD, Faheemuddin A. Ahmed, MD and Steven R. Cohen, M, D.

CMS Open Payments shows 10 general payments to Dr. Wesson from 3 drug and device companies from 2018 to 2021. Consulting fees make up the largest share, 97% of the total. Merck Sharp & Dohme Corporation paid the most, $3,750.

Dr. Wesson graduated from Medical College of Wisconsin in 1994.